¼¼°èÀÇ ¹«Ç÷û ¹èÁö ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°, ¿ëµµ, À¯Çü, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªº° ºÐ¼®(2023-2030³â)
Global Serum-free Media Market Size study & Forecast, by Product, by Application, by Type, by End-User and Regional Analysis, 2023-2030
»óǰÄÚµå : 1334630
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2023³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,881,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,689,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¹«Ç÷û ¹èÁö ½ÃÀåÀº 2022³â ¾à 14¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 13.03% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹«Ç÷û ¹èÁö´Â ¼¼Æ÷ÀÇ ¼ºÀåÀ» À§ÇØ µ¿¹°ÀÇ Ç÷ûÀÌ ÇÊ¿äÇÏÁö ¾Ê±â ¶§¹®¿¡ ÀûÀýÇÑ ºñÀ²ÀÇ ¿µ¾ç¼Ò¿Í È£¸£¸óÀ» ÇÔÀ¯Çϰí ÀÖ½À´Ï´Ù. ¼¼Æ÷ ¹è¾ç¿ë ¹«Ç÷û ¹èÁö´Â »ý»ê¼º ¹× Àϰü¼º Çâ»ó, Á¤Á¦ ¹× ´Ù¿î½ºÆ®¸² ó¸® ¿ëÀ̼º µî ¸¹Àº ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹«Ç÷û ¹èÁö Á¦Á¦´Â ƯÁ¤ ¼¼Æ÷ À¯Çü¿¡ ´ëÇÑ ¼±ÅÃÀû Áõ½ÄÁ¦¸¦ Á¶ÇÕÇÏ¿© Æ÷ÇÔÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹«Ç÷û ¹èÁö Á¦Á¦´Â ÇÏÀ̺긮µµ¸¶ ¼¼Æ÷ÁÖ, ÀçÁ¶ÇÕ ´Ü¹éÁúÀ» »ý»êÇÏ´Â Áß±¹ ÇܽºÅÍ ³­¼Ò(CHO) ¼¼Æ÷ÁÖ, ¹ÙÀÌ·¯½º »ý»ê ¼÷ÁÖ ¼¼Æ÷ÁÖ(293, VERO, MDCK, MDBK µî)¸¦ Æ÷ÇÔÇÑ ¸¹Àº 1Â÷ ¹è¾ç ¹× ¼¼Æ÷ÁÖ¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹«Ç÷û ¹èÁö ½ÃÀåÀÇ ¼ºÀåÀº ¼¼Æ÷ ±â¹Ý Ä¡·áÁ¦¿¡ ´ëÇÑ °ü½É Áõ°¡, »õ·Î¿î ¹ÙÀÌ¿ÀÀǾàǰÀÇ »ý»ê Áõ°¡, ¼¼Æ÷ ¹è¾ç¿¡¼­ CHO ¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ´ë±Ô¸ð »ý»ê µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

Statista¿¡ µû¸£¸é, ¼¼°è ¼¼Æ÷ ¹è¾ç ½ÃÀåÀº 2022³â ¾à 192¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2030³â±îÁö CAGR 7.2%·Î 330¾ï ´Þ·¯ ÀÌ»óÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, FDA ½ÂÀÎ ¹× ÀÓ»ó½ÃÇè Áõ°¡, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °øµ¿ ¿¬±¸¿Í °°Àº Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê°¡ ½ÃÀåÀ» È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀåÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áٱ⼼Æ÷ ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡¿Í ¹Ìµð¾î¸¦ ÅëÇÑ Áø´Ü °Ë»ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå¿¡ dzºÎÇÑ ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Regenerative Medicine)Àº ½ÉºÎÀü, ³úÁ¹Áß, ƯÁ¤ ô¼öÁ¾¾ç ¹× ³úÁ¾¾ç Ä¡·á¸¦ À§ÇÑ Àΰ£ ÃÖÃÊÀÇ Áٱ⼼Æ÷ ÀÓ»ó½ÃÇèÀ» ½ÃÀÛÇϱâ À§ÇØ ½ºÅÄÆ÷µå ´ëÇÐÀÇ ÀÇ»ç ¿¬±¸¿øµé¿¡°Ô ¾à 3,100¸¸ ´Þ·¯¸¦ Áö¿øÇß½À´Ï´Ù. ±×·¯³ª »ý»ê °øÁ¤°ú ³ôÀº R&D ºñ¿ëÀº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹«Ç÷û ¹èÁö ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â °­·ÂÇÑ R&D ÀÎÇÁ¶ó¿Í ¿ìÈ£Àû ÀÎ ±ÔÁ¦ ȯ°æÀÇ Á¸Àç·Î ÀÎÇØ 2022³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, ÈÄÁöÇʸ§ Ȧµù½º´Â 2022³â 11¿ù ³ë½ºÄ³·Ñ¶óÀ̳ªÁÖ ¸®¼­Ä¡ Æ®¶óÀÌ¾Þ±Û ÆÄÅ©(RTP)¿¡ 1¾ï 8,800¸¸ ´Þ·¯¸¦ ÅõÀÚÇÏ¿© ¹«Ç÷û ¹èÁö Á¦Á¶ °øÀåÀ» °Ç¼³Çß½À´Ï´Ù. ±×·¯³ª ¸¸¼º ¹× ÁßÁõ Áúȯ¿¡ ´ëÇÑ ¿¬±¸°³¹ß ¹× ÀÓ»ó½ÃÇè ÇÁ·Î±×·¥ÀÌ ¸Å³â Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¹«Ç÷û ¹èÁö ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

Á¦3Àå ¹«Ç÷û ¹èÁö ¼¼°è ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ ¹«Ç÷û ¹èÁö ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ¹«Ç÷û ¹èÁö ¼¼°è ½ÃÀå : Á¦Ç°º°

Á¦6Àå ¹«Ç÷û ¹èÁö ¼¼°è ½ÃÀå : ¿ëµµº°

Á¦7Àå ¹«Ç÷û ¹èÁö ¼¼°è ½ÃÀå : À¯Çüº°

Á¦8Àå ¹«Ç÷û ¹èÁö ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¹«Ç÷û ¹èÁö ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

Á¦10Àå °æÀï Á¤º¸

Á¦11Àå Á¶»ç °úÁ¤

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Serum-free Media Market is valued approximately at USD 1.46 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.03% over the forecast period 2023-2030. Serum-free media contains proper ratios of nutrients and hormones because they don't require animal serum for cell growth. Serum-free media for cell culture has a number of advantages, including increased productivity and consistency as well as easier purification and downstream processing. In addition, serum-free media formulations can contain combinations of selective growth agents for specific cell types. Serum-free medium formulations are available for many primary cultures and cell lines, including hybridoma cell lines, Chinese hamster ovary (CHO) lines that produce recombinant proteins, and cell lines that act as hosts for virus production (e.g., 293, VERO, MDCK, MDBK). The market growth of serum-free media is driven by factors such as rising focus on cell-based therapeutics, growing production of new biopharmaceuticals and large scale manufacturing with CHO cells in cell culture.

According to Statista, the global cell culture market reached around USD 19.2 billion in 2022 and it is expected that by 2030, the market would be worth more than USD 33 billion, with a CAGR of 7.2%. More FDA approvals, clinical trials, and strategic initiatives such collaborations by the key market players is expanding the market. Moreover, increasing funding in stem cell research and rising awareness of media-based diagnostic testing may create abundant opportunities for the market in the forecast years. In September 2021, the California Institute for Regenerative Medicine awarded Stanford physician-researchers almost USD 31.0 million to begin the first-in-human stem cell clinical trials for the treatment of heart failure, stroke, and a specific form of spinal cord and brain tumor. However, the high cost of production process and high research and Development costs may stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Serum-free Media Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share due to the existence of a strong R&D infrastructure and a supportive regulatory environment, both of which are quickly changing to accommodate the sector's continual scientific advancement. For instance, in November 2022, FUJIFILM Holdings Corporation invested USD 188.0 million in Research Triangle Park (RTP), North Carolina, to construct a manufacturing plant for serum-free media. However, Asia Pacific is expected to be the fastest growing region during the forecast period, due to more R&D and clinical trial programs for chronic and serious illnesses every year.

Major market player included in this report are:

Recent Developments in the Market:

Global Serum-free Media Market Report Scope:

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

By Application:

By Type:

By End-User:

By Region:

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Global Serum-free Media Market Definition and Scope

Chapter 3. Global Serum-free Media Market Dynamics

Chapter 4. Global Serum-free Media Market: Industry Analysis

Chapter 5. Global Serum-free Media Market, by Product

Chapter 6. Global Serum-free Media Market, by Application

Chapter 7. Global Serum-free Media Market, by Type

Chapter 8. Global Serum-free Media Market, by End-User

Chapter 9. Global Serum-free Media Market, Regional Analysis

Chapter 10. Competitive Intelligence

Chapter 11. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â